The planned deregulation of New Genomic Techniques (NGTs) in the EU would shift safety testing and liability risks for plants produced with NGTs, and the products derived from them, from biotech companies to the food industry. These consequences, up until now unnoticed, of the EU Commission’s plans to…
Please follow and like us:
